counterfeit medicines
Keeping tabs on pharma: Pfizer aims for clinical trial diversity and EMA urges public to be aware of falsified medicines in face of Covid-19 pandemic
May 07 by Emily UwemedimoPfizer’s latest TV ad encourages underrepresented groups to consider participating in clinical trials
Serialisation Implementation Timeline
August 25 by Pharmaceuticals & Biotechnology EditorFollowing the release of the EU Falsified Medicines Directive, the pharma market is in the process of becoming fully serialised ahead of 2018’s deadline. Market players currently st...
Serialisation: Top Tech Integration Considerations
August 02 by Pharmaceuticals & Biotechnology EditorRoger Bate from the American Enterprise Institute estimates that global economy is hit by $10 billion in losses due to counterfeit and substandard medicines alone. Life loss, he estimates, equat...
Serialisation Deadlines- Printable WorldMap
July 28 by Pharmaceuticals & Biotechnology EditorAs the pharmaceutical industry prepares for various approaching serialisation deadlines all over the globe, Pharma IQ has created a printable map to assist with your worldwide compliance effor...
Global Traceability and Serialisation in Pharma Report
June 29 by Pharmaceuticals & Biotechnology EditorFake pharmaceuticals have the potential to be harmful for consumption. This possibility was seen back in 2013 when the FDA alerted the industry of the existence of a counterfeit cancer medicine that w...
Factors Influencing Clinical Trial Site Selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)
December 04 by Pharmaceuticals & Biotechnology EditorThe SAT-EU study group, an independent non-profit collaborative initiative, supported by the European Forum for Good Clinical Practice (EFGCP) and several other trade and not-for profit organisation...
Standardising Serialisation: The Deadly World of Falsified and Substandard Medicines
June 18 by Andrea CharlesJust in the last few months, another dangerous fake drug made its way into the United States, a bogus version of the cancer drug Avastin surfaced in clinics across America in California, Ill...
Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and
October 03 by Pharma IQ NewsCounterfeiting in Pharmaceuticals has become a Global Program and Almost no Country is Immune to it Even though the extent of counterfeiting and its harmful consequences are more concentrated in d...
Fighting Counterfeit Medicines: What's Next?
March 08 by Andrea CharlesJim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ to discuss pharmaceutical counterfeiting, new EU legislation and EAASM’s recommendations. [inlinead]
The Counterfeiting Superhighway from the EAASM
November 25 by Pharmaceuticals & Biotechnology EditorEuropean Alliance for Access to Safe Medicines (EAASM) report on pharmaceutical anti-counterfeiting. Threat from counterfeit medicines and likelihood of medicines purchased online being counterfeit,...
Catching the Counterfeiters: Efforts to Combat Global Drug Counterfeiting Intensify
November 23 by Pharma IQDespite measures intended to stem the tide of counterfeit medicines entering the market, figures from the United Nations Office on Drugs and Crime suggest that smugglers are capable of making &eur...
Securing the Supply Chain to Combat Counterfeit Medicines
September 07 by Pharma IQCounterfeit medicines present a serious challenge for the pharmaceutical industry. As well as the dangers to public health presented by such drugs, the presence of counterfeit medicines serves to redu...